Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Autor: Jacobson, Ira M, Dore, Gregory J, Foster, Graham R, Fried, Michael W, Radu, Monica, Rafalsky, Vladimir V, Moroz, Larysa, Craxi, Antonio, Peeters, Monika, Lenz, Oliver, Ouwerkerk-Mahadevan, Sivi, De La Rosa, Guy, Kalmeijer, Ronald, Scott, Jane, Sinha, Rekha, Beumont-Mauviel, Maria
Zdroj: In The Lancet 2-8 August 2014 384(9941):403-413
Databáze: ScienceDirect